The global brain monitoring market was worth USD 6.2 billion in 2020 and is further projected to reach USD 9.3 billion by the year 2027, growing at a CAGR of 5.8% in the forecast period. The increasing prevalence of neurological disorders, as well as cardiovascular diseases, are some of the leading factors driving the growth of the market.